Circulating Tumor DNA as Marker of Therapeutic Efficacy in Breast Cancer Patients
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Neoplasms
Interventions: OTHER: ctDNA level during neoadjuant chemotherapy
Sponsor: First Affiliated Hospital Xi'an Jiaotong University